Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:2398-2400
Published online before print May 17, 2004, doi: 10.1161/01.CIR.0000129232.61483.43
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/20/2398    most recent
01.CIR.0000129232.61483.43v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawai, Y.
Right arrow Articles by Yasuda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawai, Y.
Right arrow Articles by Yasuda, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Other diagnostic testing

(Circulation. 2004;109:2398-2400.)
© 2004 American Heart Association, Inc.


Brief Rapid Communications

Diagnostic Use of Serum Deoxyribonuclease I Activity as a Novel Early-Phase Marker in Acute Myocardial Infarction

Yasuyuki Kawai, MD; Masahiro Yoshida, MD; Kenichiro Arakawa, MD; Teruhiko Kumamoto, MD; Norihiro Morikawa, MD; Katsuhiko Masamura, MD; Hiroshi Tada, MD; Sachiko Ito, MD; Hiroshi Hoshizaki, MD; Shigeru Oshima, MD; Koichi Taniguchi, MD; Hidekazu Terasawa, MD; Isamu Miyamori, MD; Koichiro Kishi, MD; Toshihiro Yasuda, PhD

From the Third Department of Internal Medicine (Y.K., M.Y., K.A., T.K., N.M., K.M., I.M.), Department of Emergency Medicine (H.T.), and Department of Biology (T.Y.), Faculty of Medical Sciences, University of Fukui, Fukui; Division of Cardiology (H.T., S.I., H.H., S.O., K.T.), Gunma Prefecture Cardiovascular Center, Gunma; and Department of Legal Medicine (K.K.), Gunma University Graduate School of Medicine, Gunma, Japan.

Correspondence to Toshihiro Yasuda, PhD, Department of Biology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan. E-mail tyasuda{at}fmsrsa.fukui-med.ac.jp

Received November 15, 2003; de novo received February 13, 2004; revision received April 8, 2004; accepted April 9, 2004.

Background— The delayed release of serum cardiac markers such as creatine kinase isoenzyme MB and equivocal early electrocardiographic changes have hampered a diagnosis of acute myocardial infarction (AMI) in the early phase after its onset. Therefore, a reliable serum biochemical marker for the diagnosis of AMI in the very early phase is desirable.

Methods and Results— Serum samples were collected from the patients with AMI, unstable angina pectoris, stable angina pectoris, and other diseases. Levels of serum deoxyribonuclease I (DNase I) activity in the patients were determined. An abrupt elevation of serum DNase I activity was observed within approximately 3 hours of the onset of symptoms in patients with AMI, with significantly higher activity levels (21.7±5.10 U/L) in this group compared with the other groups with unstable angina pectoris (10.4±4.41 U/L), angina pectoris (10.8±3.70 U/L), and other diseases (9.22±4.16 U/L). Levels of the DNase I activity in serum then exhibited a marked time-dependent decline within 12 hours and had returned to basal levels within 24 hours.

Conclusions— We suggest that serum DNase I activity could be used as a new diagnostic marker for the early detection of AMI.


Key Words: myocardial infarction • enzymes • diagnosis




This article has been cited by other articles:


Home page
Eur Heart JHome page
N. Morikawa, Y. Kawai, K. Arakawa, T. Kumamoto, I. Miyamori, H. Akao, M. Kitayama, K. Kajinami, J.-D. Lee, H. Takeshita, et al.
Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test
Eur. Heart J., December 2, 2007; 28(24): 2992 - 2997.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Giannitsis and H. A. Katus
Ability of DNase I activity to detect myocardial ischaemia in vasospastic angina a view through a monocle?
Eur. Heart J., December 2, 2007; 28(24): 2955 - 2956.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. Kumamoto, Y. Kawai, K. Arakawa, N. Morikawa, J. Kuribara, H. Tada, K. Taniguchi, R. Tatami, I. Miyamori, Y. Kominato, et al.
Association of Gln222Arg polymorphism in the deoxyribonuclease I (DNase I) gene with myocardial infarction in Japanese patients
Eur. Heart J., September 1, 2006; 27(17): 2081 - 2087.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. Cipollone
Deoxyribonuclease I: exploring the hidden side of myocardial infarction
Eur. Heart J., September 1, 2006; 27(17): 2031 - 2033.
[Full Text] [PDF]


Home page
Eur Heart JHome page
K. Arakawa, Y. Kawai, T. Kumamoto, N. Morikawa, M. Yoshida, H. Tada, R. Kawaguchi, K. Taniguchi, I. Miyamori, Y. Kominato, et al.
Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischaemia induced by percutaneous coronary intervention
Eur. Heart J., November 2, 2005; 26(22): 2375 - 2380.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Giannitsis and H. A. Katus
Mirror, mirror on the wall: the quest for the earliest marker of myocardial ischaemia
Eur. Heart J., November 2, 2005; 26(22): 2349 - 2350.
[Full Text] [PDF]